US Patent 10464996 Methods for the treatment of neurodegeneration
Patent 10464996 was granted and assigned to Momenta Pharmaceuticals on November, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
May 13, 2014
Date of Patent
November 5, 2019
Patent Applicant
Patent Application Number
14890865
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10464996 Methods for the treatment of neurodegeneration
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.